Phase II study of taxotere as first line chemotherapy for metastatic breast cancer (MBC); A National Cancer Institute of Canada Clinical Trial Group (NCICCTG) study

• TRUDEAU ME.

収録刊行物

• Proc Am Soc Clin Oncol

  Proc Am Soc Clin Oncol 12 63-, 1993

詳細情報

• CRID: 1571980074577659648
• NII論文ID: 10008094927
• データソース種別:
  • CiNii Articles